These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23069849)

  • 1. Polymorphism in protein tyrosine phosphatase receptor delta is associated with the risk of clear cell renal cell carcinoma.
    Du Y; Su T; Tan X; Li X; Xie J; Wang G; Shen J; Hou J; Cao G
    Gene; 2013 Jan; 512(1):64-9. PubMed ID: 23069849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D9S168 microsatellite alteration predicts a poor prognosis in patients with clear cell renal cell carcinoma and correlates with the down-regulation of protein tyrosine phosphatase receptor delta.
    Li X; Tan X; Yu Y; Chen H; Chang W; Hou J; Xu D; Ma L; Cao G
    Cancer; 2011 Sep; 117(18):4201-11. PubMed ID: 21387281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour behaviour in men.
    Safarinejad MR; Shafiei N; Safarinejad S
    Clin Oncol (R Coll Radiol); 2012 May; 24(4):269-81. PubMed ID: 21489764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor binding protein-3 (IGFBP-3) gene variants are associated with renal cell carcinoma.
    Safarinejad MR
    BJU Int; 2011 Sep; 108(5):762-70. PubMed ID: 21314884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender-specific association of methylenetetrahydrofolate reductase genotype and haplotype with the aggressiveness and prognosis of clear cell renal cell carcinoma in Japanese patients.
    Sakano S; Hinoda Y; Okayama N; Kawai Y; Ito H; Nagao K; Hara T; Matsuyama H
    BJU Int; 2010 Aug; 106(3):424-30. PubMed ID: 20039875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.
    Kruck S; Merseburger AS; Hennenlotter J; Scharpf M; Eyrich C; Amend B; Sievert KD; Stenzl A; Bedke J
    BJU Int; 2012 May; 109(10):1565-70. PubMed ID: 21981759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAI-1 expression and its regulation by promoter 4G/5G polymorphism in clear cell renal cell carcinoma.
    Choi JW; Lee JH; Park HS; Kim YS
    J Clin Pathol; 2011 Oct; 64(10):893-7. PubMed ID: 21725041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bcl2 -938CC genotype has poor prognosis and lower survival in renal cancer.
    Hirata H; Hinoda Y; Nakajima K; Kikuno N; Suehiro Y; Tabatabai ZL; Ishii N; Dahiya R
    J Urol; 2009 Aug; 182(2):721-7. PubMed ID: 19539330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTLA-4 and CD28 genes' polymorphisms and renal cell carcinoma susceptibility in the Polish population--a prospective study.
    Tupikowski K; Partyka A; Kolodziej A; Dembowski J; Debinski P; Halon A; Zdrojowy R; Frydecka I; Karabon L
    Tissue Antigens; 2015 Nov; 86(5):353-61. PubMed ID: 26403483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEGF polymorphisms are associated with an increasing risk of developing renal cell carcinoma.
    Bruyère F; Hovens CM; Marson MN; d'Arcier BF; Costello AJ; Watier H; Linassier C; Ohresser M
    J Urol; 2010 Oct; 184(4):1273-8. PubMed ID: 20723915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D receptor gene polymorphisms are associated with increased risk and progression of renal cell carcinoma in a Japanese population.
    Obara W; Suzuki Y; Kato K; Tanji S; Konda R; Fujioka T
    Int J Urol; 2007 Jun; 14(6):483-7. PubMed ID: 17593089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined effects of DNA methyltransferase 1 and 3A polymorphisms and urinary total arsenic levels on the risk for clear cell renal cell carcinoma.
    Yang SM; Huang CY; Shiue HS; Pu YS; Hsieh YH; Chen WJ; Lin YC; Hsueh YM
    Toxicol Appl Pharmacol; 2016 Aug; 305():103-110. PubMed ID: 27292127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of DNA repair genes are associated with renal cell carcinoma.
    Hirata H; Hinoda Y; Matsuyama H; Tanaka Y; Okayama N; Suehiro Y; Zhao H; Urakami S; Kawamoto K; Kawakami T; Igawa M; Naito K; Dahiya R
    Biochem Biophys Res Commun; 2006 Apr; 342(4):1058-62. PubMed ID: 16510122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas.
    Allory Y; Matsuoka Y; Bazille C; Christensen EI; Ronco P; Debiec H
    Clin Cancer Res; 2005 Feb; 11(3):1190-7. PubMed ID: 15709188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose transporter polymorphisms are associated with clear-cell renal carcinoma.
    Page T; Hodgkinson AD; Ollerenshaw M; Hammonds JC; Demaine AG
    Cancer Genet Cytogenet; 2005 Dec; 163(2):151-5. PubMed ID: 16337858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capn4 mRNA level is correlated with tumour progression and clinical outcome in clear cell renal cell carcinoma.
    Zhuang Q; Qian X; Cao Y; Fan M; Xu X; He X
    J Int Med Res; 2014 Apr; 42(2):282-91. PubMed ID: 24514433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas.
    Kawai Y; Sakano S; Korenaga Y; Eguchi S; Naito K
    Eur Urol; 2007 Oct; 52(4):1147-55. PubMed ID: 17287073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The expression and clinical significance of Annexin II in clear-cell renal cell carcinoma].
    Yang J; Cheng TT; Wang LN; Chen W; Li X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jan; 28(1):59-62. PubMed ID: 22230505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of interleukin-18 polymorphisms-607 and -137 on clinical characteristics of renal cell carcinoma patients.
    Sáenz-López P; Carretero R; Vazquez F; Martin J; Sánchez E; Tallada M; Garrido F; Cózar JM; Ruiz-Cabello F
    Hum Immunol; 2010 Mar; 71(3):309-13. PubMed ID: 19961892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
    Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
    BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.